Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
Clinical trial NCT00002925 · COMPLETED
Trial details
- NCT number
- NCT00002925
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1997-02-01
- Primary completion
- 2003-11-01
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.